{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:56:15Z","timestamp":1773798975221,"version":"3.50.1"},"reference-count":110,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T00:00:00Z","timestamp":1545609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/16\/85\/32471"],"award-info":[{"award-number":["PG\/16\/85\/32471"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/18\/44\/33790"],"award-info":[{"award-number":["PG\/18\/44\/33790"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Health Research University College London Hospitals Biomedical Research Centre"},{"DOI":"10.13039\/501100006692","name":"Universit\u00e0 degli Studi di Torino","doi-asserted-by":"publisher","award":["PAGP_RIC_LOC_16_01"],"award-info":[{"award-number":["PAGP_RIC_LOC_16_01"]}],"id":[{"id":"10.13039\/501100006692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006692","name":"Universit\u00e0 degli Studi di Torino","doi-asserted-by":"publisher","award":["PAGP_RILO_17_01"],"award-info":[{"award-number":["PAGP_RILO_17_01"]}],"id":[{"id":"10.13039\/501100006692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006692","name":"Universit\u00e0 degli Studi di Torino","doi-asserted-by":"publisher","award":["PENC_RILO_17_01"],"award-info":[{"award-number":["PENC_RILO_17_01"]}],"id":[{"id":"10.13039\/501100006692","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Astra Zeneca"},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim Pharmaceuticals","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Russian Government Program"},{"DOI":"10.13039\/501100012528","name":"Kazan Federal University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012528","id-type":"DOI","asserted-by":"crossref"}]},{"name":"SHF-Foundation","award":["SHF\/FG657P\/2017"],"award-info":[{"award-number":["SHF\/FG657P\/2017"]}]},{"name":"von Behring-R\u00f6ntgen-Foundation"},{"name":"National Research, Development and Innovation Office of Hungary","award":["NVKP_16-1-2016-0017"],"award-info":[{"award-number":["NVKP_16-1-2016-0017"]}]},{"DOI":"10.13039\/501100003549","name":"OTKA","doi-asserted-by":"publisher","award":["KH 125570"],"award-info":[{"award-number":["KH 125570"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003549","name":"OTKA","doi-asserted-by":"publisher","award":["115378"],"award-info":[{"award-number":["115378"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Higher Education Institutional Excellence Programme of the Ministry of Human Capacities in Hungary"},{"name":"Therapeutic Development"},{"DOI":"10.13039\/501100002332","name":"Semmelweis University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"ERDF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Operational Program for Competitiveness Factors"},{"name":"Excellence Cluster Cardio-pulmonary System"},{"name":"ECCPS"},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"COST Action EU-CARDIOPROTECTION","award":["CA16225"],"award-info":[{"award-number":["CA16225"]}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1093\/cvr\/cvy314","type":"journal-article","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T15:13:20Z","timestamp":1545146000000},"page":"1156-1166","source":"Crossref","is-referenced-by-count":129,"title":["Circulating blood cells and extracellular vesicles in acute cardioprotection"],"prefix":"10.1093","volume":"115","author":[{"given":"Sean M","family":"Davidson","sequence":"first","affiliation":[{"name":"The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London, UK"}]},{"given":"Ioanna","family":"Andreadou","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece"}]},{"given":"Lucio","family":"Barile","sequence":"additional","affiliation":[{"name":"Cellular and Molecular Cardiology Laboratory, Cardiocentro Ticino Foundation and Swiss Institute for Regenerative Medicine (SIRM), Lugano, Switzerland"}]},{"given":"Yochai","family":"Birnbaum","sequence":"additional","affiliation":[{"name":"Section of Cardiology, Department of Medicine, Baylor College of Medicine and The Texas Heart Institute, Baylor St. Luke Medical Center, MS BCM620, One Baylor Plaza, Houston, TX77030, USA"}]},{"given":"Hector A","family":"Cabrera-Fuentes","sequence":"additional","affiliation":[{"name":"Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School, Singapore, Singapore"},{"name":"National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore, Singapore"},{"name":"Escuela de Ingenier\u00eda y Ciencias, Tecnol\u00f3gico de Monterrey, Centro de Biotecnolog\u00eda-FEMSA, Monterrey, Nuevo Le\u00f3n, Mexico"},{"name":"Department of Microbiology, Kazan Federal University, Kazan, Russian Federation"},{"name":"Institute of Biochemistry, Medical School, Justus-Liebig-University, Giessen, Germany"}]},{"given":"Michael V","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of South Alabama, College of Medicine, Mobile, AL, USA"},{"name":"Department of Physiology and Cell Biology, University of South Alabama, College of Medicine, Mobile, AL, USA"}]},{"given":"James M","family":"Downey","sequence":"additional","affiliation":[{"name":"Department of Physiology and Cell Biology, University of South Alabama, College of Medicine, Mobile, AL, USA"}]},{"given":"Henrique","family":"Girao","sequence":"additional","affiliation":[{"name":"Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Coimbra, Portugal"},{"name":"CNC.IBILI, University of Coimbra, Coimbra, Portugal"}]},{"given":"Pasquale","family":"Pagliaro","sequence":"additional","affiliation":[{"name":"Department of Biological and Clinical Sciences, University of Turin, Torino, Italy"},{"name":"National Institute for Cardiovascular Research, Bologna, Italy"}]},{"given":"Claudia","family":"Penna","sequence":"additional","affiliation":[{"name":"Department of Biological and Clinical Sciences, University of Turin, Torino, Italy"},{"name":"National Institute for Cardiovascular Research, Bologna, Italy"}]},{"given":"John","family":"Pernow","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden"}]},{"given":"Klaus T","family":"Preissner","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Medical School, Justus-Liebig-University, Giessen, Germany"}]},{"given":"P\u00e9ter","family":"Ferdinandy","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Semmelweis University, Nagyv\u00e1rad t\u00e9r 4, Budapest 1089, Hungary"},{"name":"Pharmahungary Group, Szeged, Hungary"}]}],"member":"286","published-online":{"date-parts":[[2018,12,24]]},"reference":[{"key":"2019052205004372600_cvy314-B1","first-page":"935","article-title":"Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations","volume":"38","author":"Hausenloy","year":"2017","journal-title":"Eur Heart J"},{"key":"2019052205004372600_cvy314-B2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/cvr\/cvx049","article-title":"Novel targets and future strategies for acute cardioprotection: position paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart","volume":"113","author":"Hausenloy","year":"2017","journal-title":"Cardiovasc Res"},{"key":"2019052205004372600_cvy314-B3","doi-asserted-by":"crossref","first-page":"70.","DOI":"10.1007\/s00395-016-0588-8","article-title":"Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery","volume":"111","author":"Hausenloy","year":"2016","journal-title":"Basic Res Cardiol"},{"key":"2019052205004372600_cvy314-B4","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/cvr\/cvx070","article-title":"Epigenomic and transcriptomic approaches in the post-genomic era: path to novel targets for diagnosis and therapy of the ischaemic heart? Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart","volume":"113","author":"Perrino","year":"2017","journal-title":"Cardiovasc Res"},{"key":"2019052205004372600_cvy314-B5","doi-asserted-by":"crossref","first-page":"904","DOI":"10.2174\/1389450116666150427154203","article-title":"Functional genomics of cardioprotection by ischemic conditioning and the influence of comorbid conditions: implications in target identification","volume":"16","author":"Varga","year":"2015","journal-title":"Curr Drug Targets"},{"key":"2019052205004372600_cvy314-B6","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.117.310820","article-title":"Critical issues for the translation of cardioprotection","volume":"120","author":"Heusch","year":"2017","journal-title":"Circ Res"},{"key":"2019052205004372600_cvy314-B7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/cvr\/cvu225","article-title":"ESC Working Group Cellular Biology of the Heart: position paper: improving the preclinical assessment of novel cardioprotective therapies","volume":"104","author":"Lecour","year":"2014","journal-title":"Cardiovasc Res"},{"key":"2019052205004372600_cvy314-B8","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1124\/pr.113.008300","article-title":"Interaction of risk factors, comorbidities, and comedications with ischemia\/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning","volume":"66","author":"Ferdinandy","year":"2014","journal-title":"Pharmacol Rev"},{"key":"2019052205004372600_cvy314-B9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jacc.2018.09.086","article-title":"Multi-target strategies to reduce myocardial ischemia\/reperfusion injury","volume":"73","author":"Davidson","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2019052205004372600_cvy314-B10","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/cvr\/cvy304","article-title":"Innate immunity as a target for acute cardioprotection","volume":"115","author":"Zuurbier","year":"2019","journal-title":"Cardiovasc Res"},{"key":"2019052205004372600_cvy314-B11","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/cvr\/cvz050","article-title":"Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities","volume":"115","author":"Andreadou","year":"2019","journal-title":"Cardiovasc Res"},{"key":"2019052205004372600_cvy314-B12","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/cvr\/cvz053","article-title":"Cardiac innervation in acute myocardial ischaemia\/reperfusion injury and cardioprotection","volume":"115","author":"Hausenloy","year":"2019","journal-title":"Cardiovasc Res"},{"key":"2019052205004372600_cvy314-B13","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/cvr\/cvy286","article-title":"The coronary circulation in acute myocardial ischaemia\/reperfusion injury: a target for cardioprotection","volume":"115","author":"Hausenloy","year":"2019","journal-title":"Cardiovasc Res"},{"key":"2019052205004372600_cvy314-B14","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1074\/jbc.M805000200","article-title":"Regulation of chemerin bioactivity by plasma carboxypeptidase N, carboxypeptidase B (activated thrombin-activable fibrinolysis inhibitor), and platelets","volume":"284","author":"Du","year":"2009","journal-title":"J Biol Chem"},{"key":"2019052205004372600_cvy314-B15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000430343","article-title":"The adipokine chemerin induces apoptosis in cardiomyocytes","volume":"37","author":"Rodriguez-Penas","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"2019052205004372600_cvy314-B16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10557-015-6622-5","article-title":"Exogenous SDF-1alpha protects human myocardium from hypoxia-reoxygenation injury via CXCR4","volume":"29","author":"Malik","year":"2015","journal-title":"Cardiovasc Drugs Ther"},{"key":"2019052205004372600_cvy314-B17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/cvr\/cvx203","article-title":"Therapeutic strategies utilizing SDF-1alpha in ischaemic cardiomyopathy","volume":"114","author":"Ziff","year":"2018","journal-title":"Cardiovasc Res"},{"key":"2019052205004372600_cvy314-B18","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/09537104.2016.1144179","article-title":"Platelet-derived sphingosine-1-phosphate and inflammation: from basic mechanisms to clinical implications","volume":"27","author":"Vito","year":"2016","journal-title":"Platelets"},{"key":"2019052205004372600_cvy314-B19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10557-015-6633-2","article-title":"Cangrelor-mediated cardioprotection requires platelets and sphingosine phosphorylation","volume":"30","author":"Cohen","year":"2016","journal-title":"Cardiovasc Drugs Ther"},{"key":"2019052205004372600_cvy314-B20","first-page":"601","article-title":"Cardioprotective role of sphingosine-1-phosphate","volume":"62","author":"Knapp","year":"2011","journal-title":"J Physiol Pharmacol"},{"key":"2019052205004372600_cvy314-B21","doi-asserted-by":"crossref","first-page":"H1429","DOI":"10.1152\/ajpheart.00358.2009","article-title":"Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning","volume":"297","author":"Vessey","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2019052205004372600_cvy314-B22","doi-asserted-by":"crossref","first-page":"H2944","DOI":"10.1152\/ajpheart.01331.2006","article-title":"Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated AKT activation protects against in vivo myocardial ischemia-reperfusion injury","volume":"292","author":"Means","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2019052205004372600_cvy314-B23","doi-asserted-by":"crossref","first-page":"H1487","DOI":"10.1152\/ajpheart.01003.2010","article-title":"Activation of Pak1\/AKT\/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury","volume":"301","author":"Egom","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2019052205004372600_cvy314-B24","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1161\/01.CIR.0000143632.06471.93","article-title":"Sphingosine kinase activation mediates ischemic preconditioning in murine heart","volume":"110","author":"Jin","year":"2004","journal-title":"Circulation"},{"key":"2019052205004372600_cvy314-B25","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1006\/jmcc.2002.1533","article-title":"Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection","volume":"34","author":"Lecour","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"2019052205004372600_cvy314-B26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4093\/dmj.2015.39.2.95","article-title":"Current antiplatelet treatment strategy in patients with diabetes mellitus","volume":"39","author":"Jung","year":"2015","journal-title":"Diabetes Metab J"},{"key":"2019052205004372600_cvy314-B27","doi-asserted-by":"crossref","first-page":"875.","DOI":"10.3389\/fphys.2018.00875","article-title":"Cardioprotective properties of human platelets are lost in uncontrolled diabetes mellitus: a study in isolated rat hearts","volume":"9","author":"Russo","year":"2018","journal-title":"Front Physiol"},{"key":"2019052205004372600_cvy314-B28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bbalip.2012.06.006","article-title":"Sphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progress","volume":"1831","author":"Karliner","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"2019052205004372600_cvy314-B29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/1074248412467692","article-title":"Platelet P2Y(1)(2) blockers confer direct postconditioning-like protection in reperfused rabbit hearts","volume":"18","author":"Yang","year":"2013","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"2019052205004372600_cvy314-B30","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/bph.13429","article-title":"Effects of P2Y12 receptor antagonists beyond platelet inhibition\u2014comparison of ticagrelor with thienopyridines","volume":"173","author":"Nylander","year":"2016","journal-title":"Br J Pharmacol"},{"key":"2019052205004372600_cvy314-B31","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1194\/jlr.M500268-JLR200","article-title":"Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets","volume":"46","author":"Tani","year":"2005","journal-title":"J Lipid Res"},{"key":"2019052205004372600_cvy314-B32","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1160\/TH09-07-0440","article-title":"Antagonism of P2Y12 or GPIIb\/IIIa receptors reduces platelet-mediated myocardial injury after ischaemia and reperfusion in isolated rat hearts","volume":"104","author":"Barrabes","year":"2010","journal-title":"Thromb Haemost"},{"key":"2019052205004372600_cvy314-B33","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-013-6474-9","article-title":"Triple therapy greatly increases myocardial salvage during ischemia\/reperfusion in the in situ rat heart","volume":"27","author":"Yang","year":"2013","journal-title":"Cardiovasc Drugs Ther"},{"key":"2019052205004372600_cvy314-B34","doi-asserted-by":"crossref","first-page":"64.","DOI":"10.1007\/s00395-017-0653-y","article-title":"The impact of irreproducibility and competing protection from P2Y12 antagonists on the discovery of cardioprotective interventions","volume":"112","author":"Cohen","year":"2017","journal-title":"Basic Res Cardiol"},{"key":"2019052205004372600_cvy314-B35","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1258\/ebm.2011.010316","article-title":"Platelet activating factor: the good and the bad in the ischemic\/reperfused heart","volume":"236","author":"Penna","year":"2011","journal-title":"Exp Biol Med (Maywood)"},{"key":"2019052205004372600_cvy314-B36","doi-asserted-by":"crossref","first-page":"H2512","DOI":"10.1152\/ajpheart.00599.2004","article-title":"Platelet-activating factor induces cardioprotection in isolated rat heart akin to ischemic preconditioning: role of phosphoinositide 3-kinase and protein kinase C activation","volume":"288","author":"Penna","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2019052205004372600_cvy314-B37","first-page":"71","article-title":"Role of platelet-activating factor in the reperfusion injury of rabbit ischemic heart","volume":"137","author":"Montrucchio","year":"1990","journal-title":"Am J Pathol"},{"key":"2019052205004372600_cvy314-B38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.redox.2013.12.027","article-title":"Endothelial nitric oxide synthase in red blood cells: key to a new erythrocrine function?","volume":"2","author":"Cortese-Krott","year":"2014","journal-title":"Redox Biol"},{"key":"2019052205004372600_cvy314-B39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000073578","article-title":"The red blood cell in vascular occlusion","volume":"32","author":"Yedgar","year":"2002","journal-title":"Pathophysiol Haemost Thromb"},{"key":"2019052205004372600_cvy314-B40","article-title":"Diagnostic and prognostic relevance of Red blood cell distribution width for vascular aging and cardiovascular diseases","author":"Poz","year":"2018","journal-title":"Rejuvenation Res"},{"key":"2019052205004372600_cvy314-B41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cardiores.2006.06.026","article-title":"Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase","volume":"72","author":"Burger","year":"2006","journal-title":"Cardiovasc Res"},{"key":"2019052205004372600_cvy314-B42","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/107424849600100405","article-title":"Cardioprotective effects of red blood cells on ischemia and reperfusion injury in isolated rat heart: release of nitric oxide as a potential mechanism","volume":"1","author":"Yang","year":"1996","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"2019052205004372600_cvy314-B43","doi-asserted-by":"crossref","first-page":"398.","DOI":"10.1007\/s00395-013-0398-1","article-title":"Depletion of circulating blood NOS3 increases severity of myocardial infarction and left ventricular dysfunction","volume":"109","author":"Merx","year":"2014","journal-title":"Basic Res Cardiol"},{"key":"2019052205004372600_cvy314-B44","doi-asserted-by":"crossref","first-page":"15049","DOI":"10.1073\/pnas.1307058110","article-title":"Arginase regulates red blood cell nitric oxide synthase and export of cardioprotective nitric oxide bioactivity","volume":"110","author":"Yang","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019052205004372600_cvy314-B45","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jacc.2018.05.052","article-title":"Erythrocytes from patients with type 2 diabetes induce endothelial dysfunction via arginase I","volume":"72","author":"Zhou","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2019052205004372600_cvy314-B46","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jacbts.2018.03.006","article-title":"Red blood cells in type 2 diabetes impair cardiac post-ischemic recovery through an arginase-dependent modulation of nitric oxide synthase and reactive oxygen species","volume":"3","author":"Yang","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"2019052205004372600_cvy314-B47","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jacc.2018.05.052","article-title":"Erythrocytes from patients with type 2 diabetes induce endothelial dysfunction via arginase I","volume":"72","author":"Zhou","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2019052205004372600_cvy314-B48","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3233\/CH-152039","article-title":"Remote ischemia preconditioning increases red blood cell deformability through red blood cell-nitric oxide synthase activation","volume":"63","author":"Grau","year":"2016","journal-title":"Clin Hemorheol Microcirc"},{"key":"2019052205004372600_cvy314-B49","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrcardio.2017.7","article-title":"Extracellular vesicles in coronary artery disease","volume":"14","author":"Boulanger","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2019052205004372600_cvy314-B50","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.mam.2017.11.004","article-title":"Exosomes and cardioprotection\u2014a critical analysis","volume":"60","author":"Davidson","year":"2018","journal-title":"Mol Aspects Med"},{"key":"2019052205004372600_cvy314-B51","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1530\/JOE-15-0201","article-title":"Microvesicles and exosomes: new players in metabolic and cardiovascular disease","volume":"228","author":"Lawson","year":"2016","journal-title":"J Endocrinol"},{"key":"2019052205004372600_cvy314-B52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/cvr\/cvx211","article-title":"Extracellular vesicles in diagnostics and therapy of the ischaemic heart: position paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology","volume":"114","author":"Sluijter","year":"2018","journal-title":"Cardiovasc Res"},{"key":"2019052205004372600_cvy314-B53","doi-asserted-by":"crossref","first-page":"e0145686.","DOI":"10.1371\/journal.pone.0145686","article-title":"Isolation of exosomes from blood plasma: qualitative and quantitative comparison of ultracentrifugation and size exclusion chromatography methods","volume":"10","author":"Baranyai","year":"2015","journal-title":"PLoS One"},{"key":"2019052205004372600_cvy314-B54","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.jacc.2015.02.026","article-title":"Plasma exosomes protect the myocardium from ischemia-reperfusion injury","volume":"65","author":"Vicencio","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2019052205004372600_cvy314-B55","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/CIRCRESAHA.113.300636","article-title":"Exosomes: nanoparticles involved in cardioprotection?","volume":"114","author":"Yellon","year":"2014","journal-title":"Circ Res"},{"key":"2019052205004372600_cvy314-B56","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.yjmcc.2014.01.004","article-title":"Cardioprotection by remote ischemic preconditioning of the rat heart is mediated by extracellular vesicles","volume":"68","author":"Giricz","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"2019052205004372600_cvy314-B57","doi-asserted-by":"crossref","first-page":"320.","DOI":"10.1038\/s41419-018-0274-x","article-title":"Plasma exosomes induced by remote ischaemic preconditioning attenuate myocardial ischaemia\/reperfusion injury by transferring miR-24","volume":"9","author":"Minghua","year":"2018","journal-title":"Cell Death Dis"},{"key":"2019052205004372600_cvy314-B58","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1182\/blood.V94.11.3791","article-title":"Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules","volume":"94","author":"Heijnen","year":"1999","journal-title":"Blood"},{"key":"2019052205004372600_cvy314-B59","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jacc.2006.10.053","article-title":"Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques","volume":"49","author":"Leroyer","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2019052205004372600_cvy314-B60","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrcardio.2015.101","article-title":"MicroRNAs in platelet function and cardiovascular disease","volume":"12","author":"McManus","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"2019052205004372600_cvy314-B61","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/cvr\/cvu167","article-title":"Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction","volume":"103","author":"Barile","year":"2014","journal-title":"Cardiovasc Res"},{"key":"2019052205004372600_cvy314-B62","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.stemcr.2014.04.006","article-title":"Exosomes as critical agents of cardiac regeneration triggered by cell therapy","volume":"2","author":"Ibrahim","year":"2014","journal-title":"Stem Cell Reports"},{"key":"2019052205004372600_cvy314-B63","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/cvr\/cvy055","article-title":"Cardioprotection by cardiac progenitor cell-secreted exosomes: role of pregnancy-associated plasma protein-A","volume":"114","author":"Barile","year":"2018","journal-title":"Cardiovasc Res"},{"key":"2019052205004372600_cvy314-B64","doi-asserted-by":"crossref","first-page":"337","DOI":"10.15252\/emmm.201606924","article-title":"Y RNA fragment in extracellular vesicles confers cardioprotection via modulation of IL-10 expression and secretion","volume":"9","author":"Cambier","year":"2017","journal-title":"EMBO Mol Med"},{"key":"2019052205004372600_cvy314-B65","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.cell.2016.01.043","article-title":"Communication by extracellular vesicles: where we are and where we need to go","volume":"164","author":"Tkach","year":"2016","journal-title":"Cell"},{"key":"2019052205004372600_cvy314-B66","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/CIRCULATIONAHA.116.024590","article-title":"Exosomal MicroRNA transfer into macrophages mediates cellular postconditioning","volume":"136","author":"de Couto","year":"2017","journal-title":"Circulation"},{"key":"2019052205004372600_cvy314-B67","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/jcmm.13302","article-title":"Cardioprotection mediated by exosomes is impaired in the setting of type II diabetes but can be rescued by the use of non-diabetic exosomes in vitro","volume":"22","author":"Davidson","year":"2018","journal-title":"J Cell Mol Med"},{"key":"2019052205004372600_cvy314-B68","doi-asserted-by":"crossref","first-page":"1169.","DOI":"10.3389\/fphys.2018.01169","article-title":"Exosomes from human cardiac progenitor cells for therapeutic applications: development of a GMP-grade manufacturing method","volume":"9","author":"Andriolo","year":"2018","journal-title":"Front Physiol"},{"key":"2019052205004372600_cvy314-B69","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2141.1967.tb08741.x","article-title":"The nature and significance of platelet products in human plasma","volume":"13","author":"Wolf","year":"1967","journal-title":"Br J Haematol"},{"key":"2019052205004372600_cvy314-B70","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.thromres.2010.01.036","article-title":"Formation of procoagulant microparticles and properties","volume":"125","author":"Freyssinet","year":"2010","journal-title":"Thromb Res"},{"key":"2019052205004372600_cvy314-B71","doi-asserted-by":"crossref","first-page":"293.","DOI":"10.3389\/fphar.2016.00293","article-title":"Role of platelet-derived microvesicles as crosstalk mediators in atherothrombosis and future pharmacology targets: a link between inflammation, atherosclerosis, and thrombosis","volume":"7","author":"Badimon","year":"2016","journal-title":"Front Pharmacol"},{"key":"2019052205004372600_cvy314-B72","doi-asserted-by":"crossref","first-page":"77.","DOI":"10.3389\/fcvm.2017.00077","article-title":"Microvesicles in atherosclerosis and angiogenesis: from bench to bedside and reverse","volume":"4","author":"Badimon","year":"2017","journal-title":"Front Cardiovasc Med"},{"key":"2019052205004372600_cvy314-B73","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cardiores.2005.04.007","article-title":"Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization","volume":"67","author":"Brill","year":"2005","journal-title":"Cardiovasc Res"},{"key":"2019052205004372600_cvy314-B74","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s10495-018-1469-4","article-title":"Protective effects of circulating microvesicles derived from ischemic preconditioning on myocardial ischemia\/reperfusion injury in rats by inhibiting endoplasmic reticulum stress","volume":"23","author":"Liu","year":"2018","journal-title":"Apoptosis"},{"key":"2019052205004372600_cvy314-B75","doi-asserted-by":"crossref","first-page":"e73304.","DOI":"10.1371\/journal.pone.0073304","article-title":"Cardiomyocyte protection by GATA-4 gene engineered mesenchymal stem cells is partially mediated by translocation of miR-221 in microvesicles","volume":"8","author":"Yu","year":"2013","journal-title":"PLoS One"},{"key":"2019052205004372600_cvy314-B76","doi-asserted-by":"crossref","first-page":"25.","DOI":"10.1186\/s12860-016-0100-1","article-title":"Microvesicles derived from hypoxia\/reoxygenation-treated human umbilical vein endothelial cells promote apoptosis and oxidative stress in H9c2 cardiomyocytes","volume":"17","author":"Zhang","year":"2016","journal-title":"BMC Cell Biol"},{"key":"2019052205004372600_cvy314-B77","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/CIRCRESAHA.117.311326","article-title":"Intra-cardiac release of extracellular vesicles shapes inflammation following myocardial infarction","volume":"123","author":"Loyer","year":"2018","journal-title":"Circ Res"},{"key":"2019052205004372600_cvy314-B78","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1161\/CIRCULATIONAHA.116.023686","article-title":"Long noncoding RNAs in cardiovascular pathology, diagnosis, and therapy","volume":"134","author":"Bar","year":"2016","journal-title":"Circulation"},{"key":"2019052205004372600_cvy314-B79","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/14728222.2018.1439015","article-title":"Non-coding RNAs as therapeutic targets for preventing myocardial ischemia-reperfusion injury","volume":"22","author":"Ong","year":"2018","journal-title":"Expert Opin Ther Targets"},{"key":"2019052205004372600_cvy314-B80","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/CIRCRESAHA.111.244442","article-title":"Inhibition of miR-15 protects against cardiac ischemic injury","volume":"110","author":"Hullinger","year":"2012","journal-title":"Circ Res"},{"key":"2019052205004372600_cvy314-B81","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1161\/CIRCULATIONAHA.113.001904","article-title":"Inhibition of microRNA-92a protects against ischemia\/reperfusion injury in a large-animal model","volume":"128","author":"Hinkel","year":"2013","journal-title":"Circulation"},{"key":"2019052205004372600_cvy314-B82","doi-asserted-by":"crossref","first-page":"H1813","DOI":"10.1152\/ajpheart.00709.2014","article-title":"MicroRNA-145 repairs infarcted myocardium by accelerating cardiomyocyte autophagy","volume":"309","author":"Higashi","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2019052205004372600_cvy314-B83","doi-asserted-by":"crossref","first-page":"H216","DOI":"10.1152\/ajpheart.00812.2013","article-title":"MicroRNAs associated with ischemia-reperfusion injury and cardioprotection by ischemic pre- and postconditioning: protectomiRs","volume":"307","author":"Varga","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2019052205004372600_cvy314-B84","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yjmcc.2017.12.010","article-title":"miR-125b is a protectomiR: a rising star for acute cardioprotection","volume":"115","author":"Varga","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"2019052205004372600_cvy314-B85","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1159\/000452506","article-title":"Ischemic postconditioning-regulated miR-499 protects the rat heart against ischemia\/reperfusion injury by inhibiting apoptosis through PDCD4","volume":"39","author":"Zhu","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"2019052205004372600_cvy314-B86","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/cvr\/cvq053","article-title":"Downregulation of microRNA-29 by antisense inhibitors and a PPAR-gamma agonist protects against myocardial ischaemia-reperfusion injury","volume":"87","author":"Ye","year":"2010","journal-title":"Cardiovasc Res"},{"key":"2019052205004372600_cvy314-B87","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1016\/j.febslet.2008.11.014","article-title":"Endogenous microRNAs induced by heat-shock reduce myocardial infarction following ischemia-reperfusion in mice","volume":"582","author":"Yin","year":"2008","journal-title":"FEBS Lett"},{"key":"2019052205004372600_cvy314-B88","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","article-title":"MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts","volume":"456","author":"Thum","year":"2008","journal-title":"Nature"},{"key":"2019052205004372600_cvy314-B89","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ymthe.2017.03.016","article-title":"Optimizing cardiac delivery of modified mRNA","volume":"25","author":"Sultana","year":"2017","journal-title":"Mol Ther"},{"key":"2019052205004372600_cvy314-B90","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1042\/BST20170037","article-title":"MicroRNA-based therapeutics in cardiovascular disease: screening and delivery to the target","volume":"46","author":"Mellis","year":"2018","journal-title":"Biochem Soc Trans"},{"key":"2019052205004372600_cvy314-B91","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrcardio.2017.18","article-title":"Antithrombotic therapy for patients with STEMI undergoing primary PCI","volume":"14","author":"Franchi","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2019052205004372600_cvy314-B92","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/iub.441","article-title":"Protease-activated receptors and myocardial infarction","volume":"63","author":"Antoniak","year":"2011","journal-title":"IUBMB Life"},{"key":"2019052205004372600_cvy314-B93","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0002-8703(97)70132-7","article-title":"Increased plasma tissue factor levels in acute myocardial infarction","volume":"134","author":"Suefuji","year":"1997","journal-title":"Am Heart J"},{"key":"2019052205004372600_cvy314-B94","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1055\/s-2003-40677","article-title":"The role of the tissue factor-thrombin pathway in cardiac ischemia-reperfusion injury","volume":"3","author":"Mackman","year":"2003","journal-title":"Semin Vasc Med"},{"key":"2019052205004372600_cvy314-B95","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/0092-8674(91)90261-V","article-title":"Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation","volume":"64","author":"Vu","year":"1991","journal-title":"Cell"},{"key":"2019052205004372600_cvy314-B96","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1182\/blood-2013-05-427708","article-title":"Inflammation, obesity, and thrombosis","volume":"122","author":"Samad","year":"2013","journal-title":"Blood"},{"key":"2019052205004372600_cvy314-B97","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s00395-007-0653-4","article-title":"SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia\/reperfusion injury in rat hearts","volume":"102","author":"Strande","year":"2007","journal-title":"Basic Res Cardiol"},{"key":"2019052205004372600_cvy314-B98","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1124\/jpet.109.162602","article-title":"Parstatin(1-26): the putative signal peptide of protease-activated receptor 1 confers potent protection from myocardial ischemia-reperfusion injury","volume":"332","author":"Routhu","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"2019052205004372600_cvy314-B99","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/cvr\/cvp122","article-title":"Parstatin: a cryptic peptide involved in cardioprotection after ischaemia and reperfusion injury","volume":"83","author":"Strande","year":"2009","journal-title":"Cardiovasc Res"},{"key":"2019052205004372600_cvy314-B100","doi-asserted-by":"crossref","first-page":"e101446.","DOI":"10.1371\/journal.pone.0101446","article-title":"Effects of exogenous recombinant APC in mouse models of ischemia reperfusion injury and of atherosclerosis","volume":"9","author":"Wildhagen","year":"2014","journal-title":"PLoS One"},{"key":"2019052205004372600_cvy314-B101","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1161\/ATVBAHA.109.188656","article-title":"Activated protein C protects against myocardial ischemia\/reperfusion injury via inhibition of apoptosis and inflammation","volume":"29","author":"Loubele","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019052205004372600_cvy314-B102","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1182\/blood-2017-05-782102","article-title":"Cytoprotective activated protein C averts Nlrp3 inflammasome-induced ischemia-reperfusion injury via mTORC1 inhibition","volume":"130","author":"Nazir","year":"2017","journal-title":"Blood"},{"key":"2019052205004372600_cvy314-B103","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1161\/ATVBAHA.110.213280","article-title":"Protease-activated receptor 2 deficiency reduces cardiac ischemia\/reperfusion injury","volume":"30","author":"Antoniak","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019052205004372600_cvy314-B104","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1073\/pnas.97.7.3678","article-title":"Protease-activated receptor-2 modulates myocardial ischemia-reperfusion injury in the rat heart","volume":"97","author":"Napoli","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019052205004372600_cvy314-B105","doi-asserted-by":"crossref","first-page":"H2004","DOI":"10.1152\/ajpheart.00909.2001","article-title":"Protease-activated receptor-2 activation improves efficiency of experimental ischemic preconditioning","volume":"282","author":"Napoli","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2019052205004372600_cvy314-B106","doi-asserted-by":"crossref","first-page":"H2845","DOI":"10.1152\/ajpheart.00209.2007","article-title":"PAR-2 activation at the time of reperfusion salvages myocardium via an ERK1\/2 pathway in in vivo rat hearts","volume":"293","author":"Jiang","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2019052205004372600_cvy314-B107","doi-asserted-by":"crossref","first-page":"R1681","DOI":"10.1152\/ajpregu.90746.2008","article-title":"Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors","volume":"297","author":"Zhong","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2019052205004372600_cvy314-B108","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.yjmcc.2015.11.030","article-title":"Protease-activated receptor 4 deficiency offers cardioprotection after acute ischemia reperfusion injury","volume":"90","author":"Kolpakov","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"2019052205004372600_cvy314-B109","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1124\/jpet.107.133595","article-title":"Inhibiting protease-activated receptor 4 limits myocardial ischemia\/reperfusion injury in rat hearts by unmasking adenosine signaling","volume":"324","author":"Strande","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"2019052205004372600_cvy314-B110","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00418-007-0300-z","article-title":"Deleterious effects of lack of cardiac PAI-1 after coronary occlusion in mice and their pathophysiologic determinants","volume":"128","author":"Zaman","year":"2007","journal-title":"Histochem Cell Biol"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cardiovascres\/article-pdf\/115\/7\/1156\/28679705\/cvy314.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T12:21:11Z","timestamp":1573561271000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/115\/7\/1156\/5258469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,24]]},"references-count":110,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,12,24]]},"published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvy314","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6,1]]},"published":{"date-parts":[[2018,12,24]]}}}